Your browser doesn't support javascript.
loading
Viral shedding and viraemia of Andes virus during acute hantavirus infection: a prospective study.
Ferrés, Marcela; Martínez-Valdebenito, Constanza; Henriquez, Carolina; Marco, Claudia; Angulo, Jenniffer; Barrera, Aldo; Palma, Carlos; Barriga Pinto, Gonzalo; Cuiza, Analia; Ferreira, Leonila; Rioseco, María Luisa; Calvo, Mario; Fritz, Ricardo; Bravo, Sebastián; Bruhn, Alejandro; Graf, Jerónimo; Llancaqueo, Alvaro; Rivera, Gonzalo; Cerda, Carolina; Tischler, Nicole; Valdivieso, Francisca; Vial, Pablo; Mertz, Gregory; Vial, Cecilia; Le Corre, Nicole.
Afiliação
  • Ferrés M; Departamento de Enfermedades Infecciosas e Inmunología Pediátricas, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Laboratorio de Infectología y Virología Molecular, Red Salud UC-Christus, Santiago, Chile. Electronic address: mferres@uc.cl.
  • Martínez-Valdebenito C; Departamento de Enfermedades Infecciosas e Inmunología Pediátricas, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Laboratorio de Infectología y Virología Molecular, Red Salud UC-Christus, Santiago, Chile.
  • Henriquez C; Departamento de Enfermedades Infecciosas e Inmunología Pediátricas, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Marco C; Departamento de Enfermedades Infecciosas e Inmunología Pediátricas, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Angulo J; Departamento de Enfermedades Infecciosas e Inmunología Pediátricas, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Laboratorio de Infectología y Virología Molecular, Red Salud UC-Christus, Santiago, Chile.
  • Barrera A; Departamento de Enfermedades Infecciosas e Inmunología Pediátricas, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Palma C; Laboratorio de Infectología y Virología Molecular, Red Salud UC-Christus, Santiago, Chile.
  • Barriga Pinto G; Laboratory of Emerging Viruses, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
  • Cuiza A; Programa Hantavirus y Zoonosis, Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago, Chile.
  • Ferreira L; Hospital Regional Guillermo Grant Benavente, Concepción, Chile.
  • Rioseco ML; Hospital Regional de Puerto Montt, Universidad San Sebastián, Sede Patagonía, Puerto Montt, Chile.
  • Calvo M; Hospital Regional de Valdivia, Valdivia, Chile.
  • Fritz R; Instituto Nacional del Tórax, Santiago, Chile.
  • Bravo S; Departamento de Medicina Intensiva, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Bruhn A; Departamento de Medicina Intensiva, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Graf J; Clínica Alemana de Santiago, Santiago, Chile.
  • Llancaqueo A; Hospital de las Higueras, Talcahuano, Chile.
  • Rivera G; Hospital Hernán Henríquez Aravena, Temuco, Chile.
  • Cerda C; Hospital Hernán Henríquez Aravena, Temuco, Chile.
  • Tischler N; Fundación Ciencia & Vida, Universidad San Sebastián, Facultad de Medicina y Ciencia, Laboratorio de Virología Molecular, Santiago, Chile.
  • Valdivieso F; Unidad Medicina del Viajero, Clinica Alemana de Santiago, Chile.
  • Vial P; Programa Hantavirus y Zoonosis, Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago, Chile; Departamento de Pediatría, Clínica Alemana de Santiago, Chile.
  • Mertz G; University of New México, Albuquerque, NM, USA.
  • Vial C; Programa Hantavirus y Zoonosis, Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago, Chile.
  • Le Corre N; Departamento de Enfermedades Infecciosas e Inmunología Pediátricas, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Laboratorio de Infectología y Virología Molecular, Red Salud UC-Christus, Santiago, Chile.
Lancet Infect Dis ; 24(7): 775-782, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38582089
ABSTRACT

BACKGROUND:

Andes virus (ANDV) is a zoonotic Orthohantavirus leading to hantavirus cardiopulmonary syndrome. Although most transmissions occur through environmental exposure to rodent faeces and urine, rare person-to-person transmission has been documented, mainly for close contacts. This study investigates the presence and infectivity of ANDV in body fluids from confirmed cases and the duration of viraemia.

METHODS:

In this prospective study, 131 participants with confirmed ANDV infection were enrolled in Chile in a prospective study between 2008 and 2022. Clinical samples (buffy coat, plasma, gingival crevicular fluid [GCF], saliva, nasopharyngeal swabs [NPS], and urine) were collected weekly for 3 weeks together with clinical and epidemiological data. Samples were categorised as acute or convalescent (up to and after 16 days following onset of symptoms). Infectivity of positive fluids was assessed after the culture of samples on Vero E6 cells and use of flow cytometry assays to determine the production of ANDV nucleoprotein.

FINDINGS:

ANDV RNA was detected in 100% of buffy coats during acute phase, declining to 95% by day 17, and to 93% between days 23-29. ANDV RNA in GCF and saliva decreased from 30% and 12%, respectively, during the acute phase, to 12% and 11% during the convalescent phase. Successful infectivity assays of RT-qPCR-positive fluids, including GCF, saliva, NPS, and urine, were observed in 18 (42%) of 43 samples obtained during the acute phase of infection. After re-culture, the capacity to infect Vero E6 cells was maintained in 16 (89%) of 18 samples. Severity was associated with the presence of ANDV RNA in one or more fluids besides blood (odds ratio 2·58 [95% CI 1·42-5·18]).

INTERPRETATION:

ANDV infection is a systemic and viraemic infection, that affects various organs. The presence of infectious particles in body fluids contributes to our understanding of potential mechanisms for person-to-person transmission, supporting the development of preventive strategies. Detection of ANDV RNA in additional fluids at hospital admission is a predictor of disease severity.

FUNDING:

National Institutes of Health and Agencia de Investigación y Desarrollo. TRANSLATION For the Spanish translation of the abstract see Supplementary Materials section.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Viremia / Orthohantavírus / Eliminação de Partículas Virais / Infecções por Hantavirus Limite: Adolescent / Adult / Aged / Animals / Child / Female / Humans / Male / Middle aged País como assunto: America do sul / Chile Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Viremia / Orthohantavírus / Eliminação de Partículas Virais / Infecções por Hantavirus Limite: Adolescent / Adult / Aged / Animals / Child / Female / Humans / Male / Middle aged País como assunto: America do sul / Chile Idioma: En Ano de publicação: 2024 Tipo de documento: Article